Logotype for Stepan Company

Stepan Company (SCL) Q1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Stepan Company

Q1 2026 earnings summary

28 Apr, 2026

Executive summary

  • Adjusted EBITDA for Q1 2026 was $49.6M, down 14% year-over-year, mainly due to lower surfactant earnings, production timing in Asia, competitive pressures in Mexico, severe weather in North America, and higher oleochemical costs.

  • Adjusted Net Income was $10.3M, a 47% decline year-over-year, primarily from lower surfactant earnings and higher interest expense related to the Pasadena, TX start-up.

  • Reported a net loss of $41.4M versus $19.7M income in prior year, driven by a $65.4M pre-tax restructuring charge.

  • Free cash flow improved 46% year-over-year to $14.0M, driven by working capital discipline, though one source notes negative free cash flow due to typical Q1 working capital needs.

  • Project Catalyst, an operational efficiency initiative, is on track to deliver $100M in pre-tax savings over two years, with ~60% expected in 2026.

Financial highlights

  • Net sales for Q1 2026 were $604.5M, up from $593.3M in Q1 2025, driven by higher selling prices and favorable currency translation.

  • Adjusted EBITDA declined 14–15% year-over-year, with surfactants down due to lower absorption and cost pressures, while polymers saw an 8% increase from margin recovery and growth in spray foam and commodity phthalic anhydride.

  • Adjusted Net Income excludes $51.2M after-tax restructuring charges, $0.5M deferred compensation expense, and $0.1M environmental remediation expense.

  • Reported net income was a loss of $41.4M, compared to a profit of $19.7M in Q1 2025, due to significant restructuring charges.

  • Adjusted earnings per diluted share was $0.45, down 46% from $0.84.

Outlook and guidance

  • FY2026 capital expenditures are guided at $105–115M, down from $122.5M in 2025.

  • Effective tax rate expected at 24–26% for 2026.

  • Project Catalyst expected to deliver $100M in pre-tax savings over two years, with ~60% realized in 2026.

  • Management expects full-year adjusted EBITDA growth, positive free cash flow, and continued balance sheet de-leveraging in 2026 despite market uncertainties.

  • Focus remains on growth in Crop Productivity, Oilfield, Tier 2/3 Surfactants, and North American Polymers.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more